03/22/2024
3:59 PM | Compass Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
03/21/2024
8:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
8:00 AM | Compass Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
9:12 AM | Boylan James P (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:03 AM | Compass Therapeutics (Issuer)
LINDAHL RICHARD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:03 AM | Compass Therapeutics (Issuer)
GRAY MARY ANN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:00 AM | Compass Therapeutics (Issuer)
Ferneau Philip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/14/2024
11:01 AM | Chiniara Ellen (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:02 AM | Compass Therapeutics (Issuer)
GORDON CARL L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
11:50 AM | Bisker-Leib Vered (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
11:49 AM | Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:50 AM | Compass Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
6:05 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Compass Therapeutics (Subject)
| Form SC 13G/A | |
02/01/2024
9:19 AM | Compass Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
01/10/2024
9:31 AM | Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
9:31 AM | Bisker-Leib Vered (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
4:30 PM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
7:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
1:08 PM | Compass Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
1:10 PM | Bisker-Leib Vered (Reporting)
Compass Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
6:30 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:30 AM | Compass Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
7:00 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
7:01 AM | Compass Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/15/2023
10:15 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
7:30 AM | Compass Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
7:32 AM | Compass Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
